Roivant Sciences is a pharmaceutical company based in New York, New York, specializing in innovative approaches to drug development and healthcare solutions. Situated in the heart of Manhattan at 151 W 42nd Street, the company focuses on advancing a diverse portfolio of therapies aimed at addressing unmet medical needs. Its location in New York City positions it within a vibrant hub of scientific research and biotechnology activity, facilitating collaboration and access to cutting-edge resources.
The company operates by identifying promising drug candidates and accelerating their development through a combination of specialized expertise and strategic partnerships. Roivant Sciences emphasizes a model that supports the efficient progression of clinical trials and regulatory approvals, often collaborating with various stakeholders to enhance the delivery of new treatments. This approach allows it to work across multiple therapeutic areas, aiming to bring effective and innovative solutions to patients.
Roivant Sciences maintains a strong presence in the pharmaceutical industry by leveraging technology and data-driven methodologies to streamline the research and development process. The company’s focus extends beyond traditional drug development to include digital health innovations, which help optimize clinical outcomes and patient engagement. Its efforts contribute to the broader goal of improving healthcare delivery through integrated and adaptive strategies.
Located in the dynamic environment of New York City, Roivant Sciences benefits from access to a large network of medical institutions, research centers, and industry experts. The company’s commitment to advancing pharmaceutical science is reflected in its continuous pursuit of novel therapies that address complex diseases. Contact can be made through their local phone number, 212-847-6204, for inquiries related to their projects and collaborations.


































